Skip to main content

Table 4 Mortality rate stratified by selected socio demographic and clinical characteristics of TB/HIV co-infected children

From: Predictors of mortality among TB-HIV co-infected children attending anti-retroviral therapy clinics of selected public hospitals in southern, Ethiopia: retrospective cohort study

Characteristics

Total

N PY

Death

N IDR

Age

≤1

18 (6.3)

75.66

1

1.32

1-5

78 (27.5)

426.33

10

2.34

6-10

136 (47.9)

590.58

20

3.38

11-15

52 (18.3)

164.58

4

2.43

Mother HIV status

Positive

219 (77.1)

1028.08

32

3.11

Negative/unknown

65 (22.9)

229.08

3

1.3

Baseline WHO stage

I & II

60 (21.1)

212

4

1.88

III & IV

224 (78.9)

1045.166

31

2.96

Baseline OI

Yes

261 (91.9)

1200

32

2.67

No

23 (8.1)

57.16

3

5.24

Baseline HIV related immune suppression

Non-significant/mild

172 (65.9)

800.167

8

9.99

Advanced

46 (16.1)

196.75

6

3.04

Sever

66 (18.1)

260.25

21

8.06

Hemoglobin level

≤10

104 (36.6)

455.91

27

5.92

> 10

180 (63.4)

801.2

8

0.99

Treatment Failure

Yes

40 (14.1)

222

3

1.35

No

244 (85.9)

1035

32

3.09

IPT

Yes

182 (64.1)

874

19

2.17

No

102 (35.9)

383.16

16

4.17

CPT

Yes

260 (91.5)

11.83

33

2.8

No

24 (8.5)

81.3375

2

2.45

Adherence

Good

266 (93.7)

1193.33

28

2.36

Fair/poor

18 (6.4)

63.83

7

10.96

Site of TB

Pulmonary

218 (76.8)

1153.66

25

2.16

Extrapulmonary

66 (23.2)

103.5

10

9.66

TB drug Resistance

No

264 (93)

1193.33

27

2.26

MDR

20 (7)

63.83

8

12.53

  1. PY person year, IDR incidence density rate.